# First Guaranty Bancshares, Inc.: financial statements, quarterly

FGBI · Nasdaq · CIK 1408534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fgbi.md) · [Financials](/companies/fgbi/financials.md) · [Filings](/companies/fgbi/filings.md) · [Insiders](/companies/fgbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fgbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [27.2](/filings/0001408534-23-000094.md) | [29.3 d](/filings/0001408534-24-000021.md) | [31.0](/filings/0001408534-24-000047.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.5](/filings/0001408534-24-000094.md) | [0.3 d](/filings/0001408534-25-000015.md) | [0.7](/filings/0001408534-25-000036.md) | [2.2](/filings/0001408534-25-000070.md) | [0.6](/filings/0001408534-25-000092.md) | [0.2 d](/filings/0001408534-26-000021.md) | [(1.8)](/filings/0001408534-26-000047.md) | [(2.2)](/filings/0001408534-26-000072.md) | [(9.0)](/filings/0001408534-25-000092.md) | [0.5 d](/filings/0001408534-26-000021.md) | [0.8](/filings/0001408534-26-000047.md) | [0.9](/filings/0001408534-26-000072.md) |
| Net income | $m | [1.8](/filings/0001408534-25-000015.md) | [1.3](/filings/0001408534-25-000015.md) | [2.3](/filings/0001408534-26-000021.md) | [7.2](/filings/0001408534-26-000021.md) | [1.9](/filings/0001408534-26-000021.md) | [1.0](/filings/0001408534-26-000021.md) | [(6.2)](/filings/0001408534-26-000072.md) | [(7.3)](/filings/0001408534-26-000072.md) | [(45.0)](/filings/0001408534-26-000021.md) | [2.5](/filings/0001408534-26-000021.md) | [2.7](/filings/0001408534-26-000072.md) | [3.4](/filings/0001408534-26-000072.md) |
| Basic EPS | $ per share | [0.10](/filings/0001408534-24-000094.md) | not reported | [0.14](/filings/0001408534-25-000036.md) | [0.53](/filings/0001408534-25-000070.md) | [0.11](/filings/0001408534-25-000092.md) | not reported | [(0.54)](/filings/0001408534-26-000047.md) | [(0.61)](/filings/0001408534-26-000072.md) | [(3.01)](/filings/0001408534-25-000092.md) | not reported | [0.14](/filings/0001408534-26-000047.md) | [0.17](/filings/0001408534-26-000072.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [3,418](/filings/0001408534-23-000094.md) | [3,553](/filings/0001408534-25-000015.md) | [3,556](/filings/0001408534-24-000047.md) | [3,616](/filings/0001408534-24-000073.md) | [3,924](/filings/0001408534-24-000094.md) | [3,973](/filings/0001408534-26-000021.md) | [3,829](/filings/0001408534-25-000036.md) | [3,970](/filings/0001408534-25-000070.md) | [3,797](/filings/0001408534-25-000092.md) | [4,078](/filings/0001408534-26-000072.md) | [3,959](/filings/0001408534-26-000047.md) | [3,895](/filings/0001408534-26-000072.md) |
| Total liabilities | $m | [3,179](/filings/0001408534-23-000094.md) | [3,303](/filings/0001408534-25-000015.md) | [3,305](/filings/0001408534-24-000047.md) | [3,360](/filings/0001408534-24-000073.md) | [3,668](/filings/0001408534-24-000094.md) | [3,718](/filings/0001408534-26-000021.md) | [3,578](/filings/0001408534-25-000036.md) | [3,706](/filings/0001408534-25-000070.md) | [3,576](/filings/0001408534-25-000092.md) | [3,852](/filings/0001408534-26-000072.md) | [3,735](/filings/0001408534-26-000047.md) | [3,668](/filings/0001408534-26-000072.md) |
| Long-term debt | $m | not reported | [209](/filings/0001408534-24-000021.md) | not reported | not reported | not reported | [195](/filings/0001408534-25-000015.md) | not reported | not reported | not reported | [179](/filings/0001408534-26-000021.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | [66.3](/filings/0001408534-25-000015.md) | not reported | not reported | not reported | [7.0](/filings/0001408534-26-000021.md) | not reported | not reported | not reported | [7.1](/filings/0001408534-26-000021.md) | not reported | not reported |
| Shareholders' equity | $m | [239](/filings/0001408534-25-000015.md) | [250](/filings/0001408534-26-000021.md) | [250](/filings/0001408534-26-000021.md) | [255](/filings/0001408534-26-000021.md) | [256](/filings/0001408534-26-000021.md) | [255](/filings/0001408534-26-000072.md) | [251](/filings/0001408534-26-000072.md) | [263](/filings/0001408534-26-000072.md) | [221](/filings/0001408534-26-000021.md) | [226](/filings/0001408534-26-000072.md) | [224](/filings/0001408534-26-000072.md) | [227](/filings/0001408534-26-000072.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.9) d](/filings/0001408534-24-000094.md) | [12.9 d](/filings/0001408534-25-000015.md) | [2.0](/filings/0001408534-25-000036.md) | [7.9 d](/filings/0001408534-25-000070.md) | [4.9 d](/filings/0001408534-25-000092.md) | [19.0 d](/filings/0001408534-26-000021.md) | [5.4](/filings/0001408534-26-000047.md) | [(18.3) d](/filings/0001408534-26-000072.md) | [29.4 d](/filings/0001408534-25-000092.md) | [(24.8) d](/filings/0001408534-26-000021.md) | [50.6](/filings/0001408534-26-000047.md) | [(0.7) d](/filings/0001408534-26-000072.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001408534-24-000094.md) | [6.6 d](/filings/0001408534-25-000015.md) | [1.6](/filings/0001408534-25-000036.md) | [1.3 d](/filings/0001408534-25-000070.md) | [(0.1) d](/filings/0001408534-25-000092.md) | [0.3 d](/filings/0001408534-26-000021.md) | [0.2](/filings/0001408534-26-000047.md) | [0.3 d](/filings/0001408534-26-000072.md) | [0.7 d](/filings/0001408534-25-000092.md) | [0.5 d](/filings/0001408534-26-000021.md) | [0.2](/filings/0001408534-26-000047.md) | [14.7 d](/filings/0001408534-26-000072.md) |
| Dividends paid | $m | [1.8 d](/filings/0001408534-24-000094.md) | [2.0 d](/filings/0001408534-25-000015.md) | [2.0](/filings/0001408534-25-000036.md) | [2.0 d](/filings/0001408534-25-000070.md) | [1.0 d](/filings/0001408534-25-000092.md) | [0.1 d](/filings/0001408534-26-000021.md) | [0.1](/filings/0001408534-26-000047.md) | [0.1 d](/filings/0001408534-26-000072.md) | [0.2 d](/filings/0001408534-25-000092.md) | [0.2 d](/filings/0001408534-26-000021.md) | [0.2](/filings/0001408534-26-000047.md) | [0.2 d](/filings/0001408534-26-000072.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

Shares outstanding: 16,539,094 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001408534-26-000072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.